Abstract

The Donath-Landsteiner (DL) test is a serologic test used to detect the presence of a biphasic hemolysin. This autoantibody is seen in patients with paroxysmal cold hemoglobinuria. The test relies on the characteristic cold binding of an IgG autoantibody with specificity to the P blood group antigen. This autoantibody causes complement-mediated red blood cell (RBC) lysis when warmed to body temperature. In this review, we describe the various methods for performing the DL test-namely a direct test, an indirect test, an indirect test with modifications such as the use of enzyme-treated RBCs and two stages, and an indirect antiglobulin DL test-and highlight the advantages and disadvantages of each. Our focus is on the indirect testing method as it is most commonly used in blood bank laboratories.

Highlights

  • Procedure Summary The procedural method for the DL test suggested by the AABB is the described indirect DL test.[5]

  • Preanalytical analysis of hemolysis should be taken into account, and special care should be taken to avoid hemolysis during the collection process

  • The DL test is the diagnostic assay for detecting the presence of a biphasic hemolysin

Read more

Summary

SEROLOGIC METHOD REVIEW

The Donath-Landsteiner (DL) test is a serologic test used to detect the presence of a biphasic hemolysin This autoantibody is seen in patients with paroxysmal cold hemoglobinuria. The test relies on the characteristic cold binding of an IgG autoantibody with specificity to the P blood group antigen This autoantibody causes complement-mediated red blood cell (RBC) lysis when warmed to body temperature. The Donath-Landsteiner (DL) test is a serologic test used to detect the presence of a biphasic hemolysin, seen in patients with paroxysmal cold hemoglobinuria (PCH). The test relies on the characteristic cold binding of an IgG autoantibody with specificity to the P blood group antigen, which causes complement-mediated red blood cell (RBC) lysis when warmed to body temperature. The patient’s RBC sample should have a positive DAT due to C3 only and no demonstrable autoantibody activity by routine methods

Procedure
Limitations
Summary
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.